Table 1—

Baseline main clinical and biochemical features of type 2 diabetic patients from the Verona Diabetes Complications Study

Evaluated at baselineReevaluated at follow-upReevaluated non- insulin-treated; complete data
n1,7801,366960
Men (%)49.248.248.9
Age (years)64 ± 0.364 ± 0.364 ± 0.3
Duration of diabetes (years)9.1 ± 0.29.5 ± 0.29.3 ± 0.2
Oral agents (%)78.179.887.5
Smokers (%)37.939.438.1
BMI (kg/m2)28.8 ± 0.1128.9 ± 0.1328.9 ± 0.14
LDL cholesterol (mmol/l)3.52 ± 0.033.48 ± 0.033.49 ± 0.03
HDL cholesterol (mmol/l)1.27 ± 0.011.28 ± 0.011.27 ± 0.01
Triglycerides (mmol/l)1.89 ± 0.031.88 ± 0.031.74 ± 0.03
Systolic blood pressure (mmHg)152 ± 0.5152 ± 0.5152 ± 0.6
Diastolic blood pressure (mmHg)88 ± 0.288 ± 0.388 ± 0.3
Fasting glucose (mmol/l)8.5 ± 0.058.6 ± 0.068.4 ± 0.06
Fasting insulin (pmol/l)111 ± 2108 ± 2102 ± 2
HOMA-IR5.86 ± 0.12*5.77 ± 0.135.54 ± 0.13
HbA1c (%)6.5 ± 0.046.4 ± 0.056.4 ± 0.04
  • Data are means ± SE.

  • *

    * n = 1,467;

  • n = 1,164.